166 related articles for article (PubMed ID: 31244428)
1. Methotrexate Hepatotoxicity in Rheumatoid Arthritis: An Analysis of the Physicians' Policy.
Anvari B
Curr Rheumatol Rev; 2020; 16(1):67-73. PubMed ID: 31244428
[TBL] [Abstract][Full Text] [Related]
2. Non-alcoholic steatohepatitis-like pattern in liver biopsy of rheumatoid arthritis patients with persistent transaminitis during low-dose methotrexate treatment.
Mori S; Arima N; Ito M; Fujiyama S; Kamo Y; Ueki Y
PLoS One; 2018; 13(8):e0203084. PubMed ID: 30142184
[TBL] [Abstract][Full Text] [Related]
3. Treatment Strategies in Early Rheumatoid Arthritis Methotrexate Management: Results From a Prospective Cohort.
Moura CS; Schieir O; Valois MF; Thorne C; Bartlett SJ; Pope JE; Hitchon CA; Boire G; Haraoui B; Hazlewood GS; Keystone EC; Tin D; Bykerk VP; Bernatsky S;
Arthritis Care Res (Hoboken); 2020 Aug; 72(8):1104-1111. PubMed ID: 31112011
[TBL] [Abstract][Full Text] [Related]
4. Quantifying the hepatotoxic risk of alcohol consumption in patients with rheumatoid arthritis taking methotrexate.
Humphreys JH; Warner A; Costello R; Lunt M; Verstappen SMM; Dixon WG
Ann Rheum Dis; 2017 Sep; 76(9):1509-1514. PubMed ID: 28341765
[TBL] [Abstract][Full Text] [Related]
5. The effect of gender on methotrexate prescription attitudes in Italian rheumatoid arthritis patients: the MARI study.
Giusti A; Epis OM; Migliore A; Ricioppo A; Sainaghi PP; Di Matteo L; Massarotti MS; Govoni M; Mazzone A; Traballi G; Ciarla S; Cozzi L; Roncaglione A; Muratore M; Laurenti R; Bianchi G
Clin Exp Rheumatol; 2019; 37(6):1003-1009. PubMed ID: 31172925
[TBL] [Abstract][Full Text] [Related]
6. Initial methotrexate dosage is not associated with an increased risk of liver toxicity in patients with rheumatoid arthritis.
Choi SR; Park JW; Lee EB; Park JK
Clin Rheumatol; 2021 Nov; 40(11):4493-4500. PubMed ID: 34115231
[TBL] [Abstract][Full Text] [Related]
7. Adherence to current recommendations on the use of methotrexate in rheumatoid arthritis in Italy: results from the MARI study.
Manara M; Bianchi G; Bruschi E; Azzolini V; Belai Beyene N; Corbanese S; De Gennaro F; Martin-Martin LS; Molica Colella AB; Pozzi MR; Romeo N; Rossini T; Severino A; Sinigaglia L
Clin Exp Rheumatol; 2016; 34(3):473-9. PubMed ID: 27050478
[TBL] [Abstract][Full Text] [Related]
8. [Therapy of rheumatoid arthritis with methotrexate. Claims data analysis of treatment patterns].
Zeidler J; Zeidler H; Graf von der Schulenburg JM
Z Rheumatol; 2012 Dec; 71(10):900-7. PubMed ID: 23052404
[TBL] [Abstract][Full Text] [Related]
9. Methotrexate hepatotoxicity in patients with rheumatoid arthritis.
Sotoudehmanesh R; Anvari B; Akhlaghi M; Shahraeeni S; Kolahdoozan S
Middle East J Dig Dis; 2010 Sep; 2(2):104-9. PubMed ID: 25197521
[TBL] [Abstract][Full Text] [Related]
10. Methotrexate-associated nonalcoholic fatty liver disease with transaminitis in rheumatoid arthritis.
Sakthiswary R; Chan GY; Koh ET; Leong KP; Thong BY
ScientificWorldJournal; 2014; 2014():823763. PubMed ID: 24971392
[TBL] [Abstract][Full Text] [Related]
11. [Methotrexate in rheumatology].
Fiehn C
Z Rheumatol; 2009 Nov; 68(9):747-56; quiz 757. PubMed ID: 19838716
[TBL] [Abstract][Full Text] [Related]
12. Factors associated with toxicity, final dose, and efficacy of methotrexate in patients with rheumatoid arthritis.
Hoekstra M; van Ede AE; Haagsma CJ; van de Laar MA; Huizinga TW; Kruijsen MW; Laan RF
Ann Rheum Dis; 2003 May; 62(5):423-6. PubMed ID: 12695153
[TBL] [Abstract][Full Text] [Related]
13. Frequency of methotrexate intolerance in rheumatoid arthritis patients using methotrexate intolerance severity score (MISS questionnaire).
Fatimah N; Salim B; Nasim A; Hussain K; Gul H; Niazi S
Clin Rheumatol; 2016 May; 35(5):1341-5. PubMed ID: 27053094
[TBL] [Abstract][Full Text] [Related]
14. Purine enzymes in patients with rheumatoid arthritis treated with methotrexate.
van Ede AE; Laan RF; De Abreu RA; Stegeman AB; van de Putte LB
Ann Rheum Dis; 2002 Dec; 61(12):1060-4. PubMed ID: 12429535
[TBL] [Abstract][Full Text] [Related]
15. Randomized controlled trial comparing 2 different starting doses of methotrexate in rheumatoid arthritis.
Dhir V; Singla M; Gupta N; Goyal P; Sagar V; Sharma A; Khanna S; Singh S
Clin Ther; 2014 Jul; 36(7):1005-15. PubMed ID: 24976447
[TBL] [Abstract][Full Text] [Related]
16. Risk factors for abnormal hepatic enzyme elevation by methotrexate treatment in patients with rheumatoid arthritis: A hospital based-cohort study.
Hakamata J; Hashiguchi M; Kaneko Y; Yamaoka K; Shimizu M; Maruyama J; Takeuchi T; Mochizuki M
Mod Rheumatol; 2018 Jul; 28(4):611-620. PubMed ID: 29252093
[TBL] [Abstract][Full Text] [Related]
17. Clinical characteristics of patients with rheumatoid arthritis and methotrexate induced pneumonitis.
Ohosone Y; Okano Y; Kameda H; Fujii T; Hama N; Hirakata M; Mimori T; Akizuki M; Ikeda Y
J Rheumatol; 1997 Dec; 24(12):2299-303. PubMed ID: 9415631
[TBL] [Abstract][Full Text] [Related]
18. Open-label observation of addition of etanercept versus a conventional disease-modifying antirheumatic drug in subjects with active rheumatoid arthritis despite methotrexate therapy in the Latin American region.
Machado DA; Guzman RM; Xavier RM; Simon JA; Mele L; Pedersen R; Ferdousi T; Koenig AS; Kotak S; Vlahos B
J Clin Rheumatol; 2014 Jan; 20(1):25-33. PubMed ID: 24356474
[TBL] [Abstract][Full Text] [Related]
19. Liver toxicity is rare in rheumatoid arthritis patients using combination therapy with leflunomide and methotrexate.
Alves JA; Fialho SC; Morato EF; Castro GR; Zimmermann AF; Ribeiro GG; Neves FS; Pereira IA
Rev Bras Reumatol; 2011; 51(2):141-4. PubMed ID: 21584420
[TBL] [Abstract][Full Text] [Related]
20. Adverse effects of low dose methotrexate in rheumatoid arthritis patients.
Gilani ST; Khan DA; Khan FA; Ahmed M
J Coll Physicians Surg Pak; 2012 Feb; 22(2):101-4. PubMed ID: 22313647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
